Table 1

Baseline characteristics of four polycystic ovary syndrome (PCOS) phenotypes and control subjects

Characteristic

PCOS

Controls


A (HA+AO+PCO)

C (HA+AO)

D (HA+PCO)


Number

72 (33.2%)

74 (34.1%)

33 (15.2%)

38 (17.5%)

48

Age, years

28.00 ± 0.59

28.74 ± 0.45

28.03 ± 0.65

28.79 ± 0.53

29.78 ± 0.56

BMI, kg/m2

24.29 ± 0.46**

24.57 ± 0.54**

25.37 ± 0.81**

24.21 ± 0.67**

21.63 ± 0.36

LH, mIU/ml

11.58 ± 0.77**

7.57 ± 1.04**

6.47 ± 0.95**

7.10 ± 1.28**

3.95 ± 0.26

LH/FSH

1.74 ± 0.10**

1.18 ± 0.17**

1.09 ± 0.12**

1.10 ± 0.14**

0.54 ± 0.03

T, nmol/l

2.06 ± 0.09**

1.26 ± 0.06*

1.73 ± 0.13**

1.95 ± 0.16**

1.31 ± 0.10

A, nmol/l

16.07 ± 0.50**

7.98 ± 0.25*

14.32 ± 0.78**

17.18 ± 1.05**

6.55 ± 0.27

CHO, mmol/l

4.84 ± 0.09*

4.66 ± 0.10

4.85 ± 0.18

5.23 ± 0.18**

4.42 ± 1.32

TG, mmol/l

1.47 ± 0.09**

1.44 ± 0.10*

1.50 ± 0.17*

1.56 ± 0.12*

1.04 ± 0.13

HDL, mmol/l

1.23 ± 0.03**

1.17 ± 0.03**

1.20 ± 0.05*

1.29 ± 0.05

1.38 ± 0.04

LDL, mmol/l

2.93 ± 0.08**

2.88 ± 0.10*

3.03 ± 0.17*

3.13 ± 0.16**

2.47 ± 0.13


Data are presented as mean ± SD. *P <0.01; **P <0.001. A = androstenedione; AO = anovulation; BMI = body mass index; CHO = cholesterol; FSH = follicle-stimulating hormone; HA = hyperandrogenism; HDL = high-density lipoprotein; LDL = low-density lipoprotein; LH = luteinizing hormone; PCO = polycystic ovaries; TG = triglyceride.

Zhao et al. BMC Medicine 2012 10:153   doi:10.1186/1741-7015-10-153

Open Data